Agilent Technologies key statistics and ratios
In fiscal 2025, Agilent Technologies had return on equity of 20.6%, an operating margin of 21.3%, debt equal to 49.8% of equity and a current ratio of 1.96. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2009Oct 2009 | 2010Oct 2010 | 2011Oct 2011 | 2012Oct 2012 | 2013Oct 2013 | 2014Oct 2014 | 2015Oct 2015 | 2016Oct 2016 | 2017Oct 2017 | 2018Oct 2018 | 2019Oct 2019 | 2020Oct 2020 | 2021Oct 2021 | 2022Oct 2022 | 2023Oct 2023 | 2024Oct 2024 | 2025Oct 2025 | LTMJul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 51.1% | 53.8% | 53.3% | 52.6% | 49.0% | 48.8% | 50.5% | 52.3% | 53.9% | 54.5% | 54.3% | 53.1% | 53.9% | 54.4% | 50.7% | 54.3% | 52.4% | 53.8% |
| Operating margin | 1.0% | 10.4% | 16.2% | 16.3% | 9.9% | 10.4% | 12.9% | 14.6% | 18.0% | 18.4% | 18.2% | 15.8% | 21.3% | 23.6% | 19.8% | 22.9% | 21.3% | 22.2% |
| Net margin | −0.7% | 12.6% | 15.3% | 16.8% | 18.8% | 13.6% | 9.9% | 11.0% | 15.3% | 6.4% | 20.7% | 13.5% | 19.1% | 18.3% | 18.1% | 19.8% | 18.8% | 19.5% |
| Free-cash-flow margin | 6.2% | 11.0% | 16.2% | 15.1% | 24.6% | 13.0% | 10.3% | 15.6% | 15.9% | 18.5% | 16.8% | 15.0% | 20.5% | 14.9% | 21.6% | 21.1% | 16.6% | 17.2% |
| Return on equity | −1.2% | 23.9% | 26.9% | 24.3% | 14.0% | 10.4% | 8.5% | 11.0% | 15.1% | 6.7% | 22.9% | 14.9% | 23.6% | 23.5% | 22.2% | 22.0% | 20.6% | 20.4% |
| Return on assets | −0.4% | 7.9% | 10.8% | 11.8% | 6.9% | 5.1% | 4.4% | 6.0% | 8.4% | 3.7% | 11.9% | 7.5% | 11.9% | 11.8% | 11.6% | 11.4% | 10.6% | 10.8% |
| Asset turnover | 0.59 | 0.63 | 0.71 | 0.70 | 0.37 | 0.38 | 0.44 | 0.55 | 0.55 | 0.58 | 0.57 | 0.56 | 0.62 | 0.64 | 0.64 | 0.58 | 0.57 | 0.55 |
| Current ratio | 3.53 | 2.00 | 3.03 | 2.45 | 3.11 | 3.26 | 3.78 | 3.85 | 3.30 | 3.33 | 1.53 | 2.33 | 2.22 | 2.03 | 2.61 | 2.09 | 1.96 | 2.05 |
| Debt to equity | 115.9% | 114.3% | 50.7% | 45.6% | 51.1% | 31.4% | 39.7% | 44.9% | 41.6% | 39.2% | 50.7% | 48.4% | 50.6% | 52.2% | 46.8% | 57.5% | 49.8% | 53.6% |
| Interest cover (operating income ÷ interest) | 0.5x | 5.9x | 12.5x | 11.1x | 3.6x | 3.8x | 7.9x | 8.5x | 10.2x | 12.1x | 12.7x | 10.8x | 16.6x | 19.3x | 14.2x | 15.5x | 13.2x | 15.5x |
| Effective tax rate | — | 0.9% | 1.5% | −7.9% | 9.3% | −0.4% | 5.5% | 9.5% | 12.2% | 66.6% | −16.5% | 14.6% | 11.0% | 16.6% | 7.4% | 15.3% | 9.2% | 13.1% |
| R&D as % of revenue | 14.3% | 11.2% | 9.8% | 9.7% | 8.7% | 8.8% | 8.2% | 7.8% | 7.6% | 7.9% | 7.8% | 9.3% | 7.0% | 6.8% | 7.0% | 7.4% | 6.5% | 6.6% |
| SG&A as % of revenue | 35.8% | 32.2% | 27.3% | 26.5% | 30.4% | 29.6% | 29.4% | 29.8% | 28.0% | 28.3% | 28.3% | 28.0% | 25.6% | 23.9% | 23.9% | 24.1% | 24.6% | 25.0% |
| Capital spending as % of revenue | 2.9% | 2.2% | 2.8% | 2.8% | 5.0% | 5.1% | 2.4% | 3.3% | 3.9% | 3.6% | 3.0% | 2.2% | 3.0% | 4.2% | 4.4% | 5.8% | 5.9% | 4.6% |
| Free cash flow ÷ net income | — | 87.3% | 105.9% | 89.7% | 130.4% | 95.8% | 103.2% | 141.6% | 104.2% | 288.0% | 80.9% | 111.5% | 107.2% | 81.4% | 118.9% | 106.5% | 88.4% | 88.0% |
| Dividends ÷ net income | — | 0.0% | 0.0% | 9.0% | 21.3% | 32.1% | 33.2% | 32.5% | 24.9% | 60.4% | 19.2% | 30.9% | 19.5% | 19.9% | 21.4% | 21.3% | 21.6% | 19.9% |
| Dividends and buybacks ÷ free cash flow | 56.1% | 68.8% | 46.4% | 26.7% | 110.3% | 71.5% | 96.6% | 89.3% | 51.1% | 67.4% | 107.3% | 86.2% | 79.0% | 136.0% | 57.0% | 103.7% | 61.4% | 52.6% |
| Quarter | 2024 Q4Oct 2024 | 2025 Q1Jan 2025 | 2025 Q2Apr 2025 | 2025 Q3Jul 2025 | 2025 Q4Oct 2025 | 2026 Q1Jan 2026 | 2026 Q2Apr 2026 | 2026 Q3Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 53.9% | 53.5% | 51.9% | 51.1% | 53.2% | 52.6% | 54.0% | 55.5% |
| Operating margin | 24.0% | 22.4% | 18.0% | 20.7% | 23.8% | 19.6% | 21.7% | 23.6% |
| Net margin | 20.6% | 18.9% | 12.9% | 19.3% | 23.3% | 17.0% | 18.5% | 19.3% |
| Free-cash-flow margin | 22.8% | 19.9% | 6.4% | 14.9% | 24.3% | 9.7% | 11.0% | 23.4% |
| Current ratio | 2.09 | 2.20 | 2.09 | 2.25 | 1.96 | 2.07 | 2.10 | 2.05 |
| Debt to equity | 57.5% | 55.8% | 57.0% | 53.5% | 49.8% | 48.6% | 47.1% | 53.6% |
| R&D as % of revenue | 6.5% | 6.7% | 6.7% | 6.4% | 6.4% | 6.5% | 6.9% | 6.5% |
| SG&A as % of revenue | 23.3% | 24.4% | 27.2% | 24.0% | 23.0% | 26.5% | 25.3% | 25.3% |
Financial health
- Short-term assets cover short-term liabilities $4.7bn of assets due within a year against $2.3bn of liabilities due within a year.
- Short-term assets cover long-term liabilities $4.7bn short-term assets against $4.3bn of longer-dated liabilities.
- More cash than debt $1.8bn of cash against $3.9bn of debt.
- Debt below 40% of shareholders' equity Debt is 54% of equity.
- Debt burden no higher than five years ago Debt to equity moved from 53% to 54% over five years.
- A year's operating cash flow covers at least 20% of debt $1.6bn of operating cash flow against $3.9bn of debt.
- Operating profit covers interest at least five times over Operating income of $1.6bn against $106m of interest.
Moat
Strong moat
How hard Agilent Technologies's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 20 / 20
Cash operating profit has been a median 14.7% of total assets over 10 years.
- Pricing power 18 / 20
Gross margin has been a median 53.7%, moving by 1.0 percentage points (standard deviation) across 10 years.
- Durability 16 / 20
Operating margin has been a median 20.3%; its worst year was 15.3%.
- Cash conversion 19 / 20
Free cash flow was positive in 10 of 10 years, at a median 17.0% of revenue.
- Discipline 19 / 20
The diluted share count fell 8.1% over five years; stock-based pay has been a median 1.8% of revenue.
AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (92 before it).
Compare with peers
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies